No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
PRPH ProPhase Labs
- 4.670
- -0.040-0.85%
Trading Apr 29 11:56 ET
84.27MMarket Cap-4765P/E (TTM)
4.835High4.650Low16.50KVolume4.770Open4.710Pre Close78.41KTurnover0.12%Turnover RatioLossP/E (Static)18.05MShares9.94152wk High1.71P/B65.61MFloat Cap4.05052wk Low--Dividend TTM14.05MShs Float15.250Historical High--Div YieldTTM3.93%Amplitude0.260Historical Low4.751Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
Garden City, NY, April 25, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a biopharma, genomics and diagnostics Company, today announced that it will be presenting at the Planet MicroC
ProPhase Labs Shares Jump on New AI-Based Project
By Dean Seal Shares of ProPhase Labs jumped after the biopharma and diagnostics company unveiled a new project that utilizes an artificial-intelligence platform and its massive genomics database. Th
ProPhase Labs Unveils Project ZenQ-AI; Leveraging ProPhase Labs' AI Platform, Massive Genomics Database And Patented Esophageal Cancer Insights For Antibody Drug Conjugates Development
Leveraging ProPhase Labs' AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development.Garden City, NY, April 16, 2024 (GLOBE NEWSWIRE) -- Pr
ProPhase Labs Unveils Project ZenQ-AI
Leveraging ProPhase Labs' AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development. Garden City, NY, April 16, 2024 (GLOBE NEWSWIRE) --
ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management With Launch of Its BE-Smart Test in H2 2024
Garden City, NY, April 10, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next-generation biotech, genomics, and diagnostics company, today reported its progress on the
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Garden City, NY, April 01, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next-generation biopharma, genomics, and diagnostics company, today announced that it has granted
Comments
$ProPhase Labs(PRPH.US$
NEWS
ProPhase Labs Unveils Project ZenQ-AI
ProPhase Labs introduces Project ZenQ-AI, leveraging AI, genomics, and esophageal cancer insights for ADC development. The project utilizes a vast genomic database and BE-Smart test to identify potential ADC candidates for personalized cancer treatments.
NEWS
ProPhase Labs Unveils Project ZenQ-AI
ProPhase Labs introduces Project ZenQ-AI, leveraging AI, genomics, and esophageal cancer insights for ADC development. The project utilizes a vast genomic database and BE-Smart test to identify potential ADC candidates for personalized cancer treatments.
$ProPhase Labs(PRPH.US$ target 9.8
1
WATCHLIST 06/13 MONDAY
$Annovis Bio(ANVS.US$
- NIA and Annovis will collaborate to develop pharmacodynamic biomarkers for buntanetap, focusing on isolating brain-derived extracellular vesicles containing potential neuronal function and viability biomarkers. Stock got analyst price target of $37
$ProPhase Labs(PRPH.US$
- Last month the company announced better than expected earnings and announced a dividend. Received Analyst price target of $14.
$JE Cleantech Holdings Limited(JCSE.US$
- Stock rece...
- NIA and Annovis will collaborate to develop pharmacodynamic biomarkers for buntanetap, focusing on isolating brain-derived extracellular vesicles containing potential neuronal function and viability biomarkers. Stock got analyst price target of $37
$ProPhase Labs(PRPH.US$
- Last month the company announced better than expected earnings and announced a dividend. Received Analyst price target of $14.
$JE Cleantech Holdings Limited(JCSE.US$
- Stock rece...
3
1
WATCHLIST 06/09 THURSDAY
$Vertex Energy(VTNR.US$
- Vertex Energy Set To Join Russell 3000 Index June 27. Stock could continue higher pre joining.
$RCM Technologies(RCMT.US$
- Stock recently broke out. Currently consolidating above $25. Possible another break out soon.
$达内科技(TEDU.US$
- On Tuesday , Co reported Q1 EPS $0.40 Up From $(0.31) YoY, Sales $98.36M Beat $58.85M Estimate. Stock breaking out.
$Annovis Bio(ANVS.US$
- NIA and Annovis will collaborate to develop pharmac...
- Vertex Energy Set To Join Russell 3000 Index June 27. Stock could continue higher pre joining.
$RCM Technologies(RCMT.US$
- Stock recently broke out. Currently consolidating above $25. Possible another break out soon.
$达内科技(TEDU.US$
- On Tuesday , Co reported Q1 EPS $0.40 Up From $(0.31) YoY, Sales $98.36M Beat $58.85M Estimate. Stock breaking out.
$Annovis Bio(ANVS.US$
- NIA and Annovis will collaborate to develop pharmac...
2
WATCHLIST 06/07 TUESDAY
$RCM Technologies(RCMT.US$ - Stock recently broke out. Now back to support. Possible move higher if holds $25.
$Houston American Energy(HUSA.US$ - Houston American Energy shares are trading higher on above-average volume as the stock trends across social media platforms.
$Obsidian Energy Ltd(OBE.US$ - Energy stock getting momentum hitting 52 week high. Breaking out of the trendline channel. Looking for more.
$Integrated Media Technology(IMTE.US$ - Stock almost hit $12.50...
$Houston American Energy(HUSA.US$ - Houston American Energy shares are trading higher on above-average volume as the stock trends across social media platforms.
$Obsidian Energy Ltd(OBE.US$ - Energy stock getting momentum hitting 52 week high. Breaking out of the trendline channel. Looking for more.
$Integrated Media Technology(IMTE.US$ - Stock almost hit $12.50...
2
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg